Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:06 PM ET 8-K
Loan & Debt Riley Exploration Permian, Inc. REPX

Riley Exploration Permian $130M Debt Financing with Truist Bank

Riley Exploration Permian, Inc. borrowed $130 million under its existing credit facility with Truist Bank to voluntarily prepay in full its 10.50% Senior Unsecured Notes due 2028. The refinancing leaves the company's total debt substantially unchanged while satisfying and discharging all obligations under the previous Note Purchase Agreement.

Value
$130M
Counterparty
Truist Bank
Term
through Dec 2028
4:06 PM ET 8-K
Investor Meeting Microvision, Inc. MVIS

Microvision Investor Meeting

MicroVision held a virtual business update event to reaffirm its 2026 revenue guidance of $10 million to $15 million and project a doubling of revenue in 2027. Management outlined a 'Lidar 2.0' strategy focused on commercial execution across industrial, defense, and AI data center markets while planning a significant reduction in cash burn for 2027.

4:06 PM ET 8-K
Executive Compensation Advasa Holdings, Inc. ADBT

Advasa Holdings Executive Compensation

Advasa Holdings appointed William Witherspoon as its new Chief Financial Officer, effective October 6, 2026. Mr. Witherspoon, who previously served as an independent director, will receive an annual base salary of $200,000 and is eligible for discretionary bonuses and equity grants. He succeeds CEO Grady Ryther, who had been serving as interim CFO since August 2026.

4:06 PM ET 8-K
Reverse Stock Split Medicus Pharma Ltd. MDCX

Medicus Pharma Reverse Stock Split

Medicus Pharma Ltd. announced a fifty-to-one (1-for-50) reverse stock split of its common shares effective October 12, 2026. The consolidation is intended to increase the per-share bid price to regain compliance with Nasdaq's minimum bid price requirement for continued listing. The split was previously authorized by shareholders at the company's annual meeting on June 3, 2026.

4:06 PM ET 8-K/A
Leadership Change Ocean Power Technologies, Inc. OPTT

Ocean Power Technologies Leadership Change

Ocean Power Technologies announced that Robert Powers departed as CFO effective September 30, 2026, and will remain through October 14, 2026, to assist with the transition. The company has appointed Victoria Hay from Flexible Consulting, LLC as interim Chief Financial Officer while conducting a search for a permanent successor. Mr. Powers will receive six months of base salary and his fiscal 2026 bonus as part of a severance agreement.

Counterparty
Flexible Consulting, LLC
4:06 PM ET 8-K
Shareholder Meeting Unusual Machines, Inc. UMAC

Unusual Machines Shareholder Meeting

Unusual Machines, Inc. held its 2026 Annual Meeting of Stockholders on October 5, 2026, where shareholders elected five directors and ratified Ernst & Young LLP as the independent auditor for the fiscal year ending December 31, 2026. Stockholders also approved a warrant grant to the company's Chief Executive Officer and an adjournment proposal, though adjournment was not necessary as all primary proposals passed.

4:06 PM ET 8-K
Leadership Change Matternet, Inc. MTTN

Matternet Leadership Change

Matternet, Inc. entered into a separation agreement with outgoing Chief Financial Officer Jason Secore, whose employment ended on September 29, 2026. Under the agreement, Mr. Secore will receive a cash payment of $156,146 and an extension of the post-termination exercise period for his equity awards. CEO Andreas Raptopoulos is currently serving as the interim CFO while the company searches for a permanent successor.

4:05 PM ET Form 4
Insider Selling Twist Bioscience Corp TWST

Twist Bioscience CEO Emily M. Leproust Sells $910K of Stock

Emily M. Leproust, CEO, sold 4,503 shares of Twist Bioscience Corp at $200.44 to $206.84 a share (average $202.10) in 7 transactions, worth $910K in total on Oct 5, 2026. Shares held after the trade: 562,805 (-0.0%).

Value
$910K
Shares
4,503
Average price
$202.10
Role
CEO
Holding change
-0.0%
Trade date
Oct 5, 2026
4:05 PM ET Form 4
Insider Selling Applied Optoelectronics, Inc. AAOI

Applied Optoelectronics *** See Remarks Shu-Hua (Joshua) Yeh Sells $720K of Stock

Shu-Hua (Joshua) Yeh, *** See Remarks, sold 6,000 shares of Applied Optoelectronics, Inc. at $120.03 a share, worth $720K in total on Oct 5, 2026. Shares held after the trade: 371,498 (-1.6%).

Value
$720K
Shares
6,000
Price
$120.03
Role
*** See Remarks
Holding change
-1.6%
Trade date
Oct 5, 2026
4:05 PM ET Form 4
Insider Selling SOPHiA Genetics SA SOPH

SOPHiA Genetics Chief People Officer Manuela Valente Sells $34.5K of Stock

Manuela Valente, Chief People Officer, sold 4,240 shares of SOPHiA Genetics SA at $8.13 a share, worth $34.5K in total on Oct 5, 2026. Shares held after the trade: 206,210 (-2.0%).

Value
$34.5K
Shares
4,240
Price
$8.13
Role
Chief People Officer
Holding change
-2.0%
Trade date
Oct 5, 2026
4:05 PM ET Form 4
Insider Selling SOPHiA Genetics SA SOPH

SOPHiA Genetics CLO Well Daan Van Sells $50.1K of Stock

Well Daan Van, CLO, sold 6,168 shares of SOPHiA Genetics SA at $8.12 a share, worth $50.1K in total on Oct 5, 2026. Shares held after the trade: 332,716 (-1.8%).

Value
$50.1K
Shares
6,168
Price
$8.12
Role
CLO
Holding change
-1.8%
Trade date
Oct 5, 2026
4:04 PM ET Form 4
Insider Selling SOPHiA Genetics SA SOPH

SOPHiA Genetics CTO Abhimanyu Verma Sells $42.9K of Stock

Abhimanyu Verma, CTO, sold 5,284 shares of SOPHiA Genetics SA at $8.12 a share, worth $42.9K in total on Oct 5, 2026. Shares held after the trade: 166,887 (-3.1%).

Value
$42.9K
Shares
5,284
Price
$8.12
Role
CTO
Holding change
-3.1%
Trade date
Oct 5, 2026
4:04 PM ET Form 4
Insider Selling SOPHiA Genetics SA SOPH

SOPHiA Genetics CMO Philippe Menu Sells $60.1K of Stock

Philippe Menu, CMO, sold 7,394 shares of SOPHiA Genetics SA at $8.13 a share, worth $60.1K in total on Oct 5, 2026. Shares held after the trade: 200,993 (-3.5%).

Value
$60.1K
Shares
7,394
Price
$8.13
Role
CMO
Holding change
-3.5%
Trade date
Oct 5, 2026
4:04 PM ET Form 4
Insider Selling SOPHiA Genetics SA SOPH

SOPHiA Genetics CFO George Cardoza Sells $12.9K of Stock

George Cardoza, CFO, sold 1,592 shares of SOPHiA Genetics SA at $8.10 a share, worth $12.9K in total on Oct 5, 2026. Shares held after the trade: 306,726 (-0.5%).

Value
$12.9K
Shares
1,592
Price
$8.10
Role
CFO
Holding change
-0.5%
Trade date
Oct 5, 2026
4:04 PM ET Form 4
Insider Selling SOPHiA Genetics SA SOPH

SOPHiA Genetics Executive Chairman Jurgi Camblong Sells $327K of Stock

Jurgi Camblong, Executive Chairman, sold 40,172 shares of SOPHiA Genetics SA at $8.13 a share, worth $327K in total on Oct 5, 2026. Shares held after the trade: 3,395,650 (-1.2%).

Value
$327K
Shares
40,172
Price
$8.13
Role
Executive Chairman
Holding change
-1.2%
Trade date
Oct 5, 2026
4:04 PM ET Form 4
Insider Selling SOPHiA Genetics SA SOPH

SOPHiA Genetics CEO Ross Muken Sells $80K of Stock

Ross Muken, CEO, sold 9,838 shares of SOPHiA Genetics SA at $8.13 a share, worth $80K in total on Oct 5, 2026. Shares held after the trade: 660,391 (-1.5%).

Value
$80K
Shares
9,838
Price
$8.13
Role
CEO
Holding change
-1.5%
Trade date
Oct 5, 2026
4:04 PM ET Form 4
Insider Selling SOPHiA Genetics SA SOPH

SOPHiA Genetics CSO Zhenyu Xu Sells $60.1K of Stock

Zhenyu Xu, CSO, sold 7,394 shares of SOPHiA Genetics SA at $8.12 a share, worth $60.1K in total on Oct 5, 2026. Shares held after the trade: 545,493 (-1.3%).

Value
$60.1K
Shares
7,394
Price
$8.12
Role
CSO
Holding change
-1.3%
Trade date
Oct 5, 2026
4:02 PM ET Form 4
Insider Selling Artiva Biotherapeutics, Inc. ARTV

Artiva Biotherapeutics CEO Fred Aslan Sells $169K of Stock

Fred Aslan, CEO, sold 23,463 shares of Artiva Biotherapeutics, Inc. at $7.20 a share, worth $169K in total on Oct 6, 2026. Shares held after the trade: 1,519,606 (-1.5%).

Value
$169K
Shares
23,463
Price
$7.20
Role
CEO
Holding change
-1.5%
Trade date
Oct 6, 2026
4:01 PM ET 8-K
Equity Investment GridAI Technologies Corp. GRDX

GridAI Technologies Equity Investment of $3.5M in Pronghorn Resources, LLC

GridAI Technologies Corp. entered into a Second Amended and Restated Secured Convertible Note with Pronghorn Resources, LLC, providing an additional $536,000 loan. This brings the total aggregate principal amount invested by GridAI into Pronghorn to $3.5 million, secured by an amended security agreement.

Value
$3.5M
Counterparty
Pronghorn Resources, LLC
4:01 PM ET 8-K
Capital Raise North Haven Net REIT

North Haven Net REIT Capital Raise of $59.6M

North Haven Net REIT sold an aggregate of 2,835,825 common shares in its continuous private offering for approximately $59.6 million. The sale included Class S, Class F-I, Class I, and Class E common shares at the company's most recently determined net asset value per share.

Value
$59.6M
4:00 PM ET Form 4
Insider Buying Intellinetics, Inc. INLX

Intellinetics Insider Robert Taglich Buys $20K of Stock

Robert Taglich bought 4,000 shares of Intellinetics, Inc. at $5.00 a share, worth $20K in total on Oct 6, 2026. Shares held after the trade: 459,338 (+0.9%).

Value
$20K
Shares
4,000
Price
$5.00
Holding change
+0.9%
Trade date
Oct 6, 2026
4:00 PM ET Form 4
Insider Selling Amylyx Pharmaceuticals, Inc. AMLX

Amylyx Pharmaceuticals Director George M. Milne Jr. Sells $831K of Stock

George M. Milne Jr., Director, sold 30,000 shares of Amylyx Pharmaceuticals, Inc. at $27.70 a share, worth $831K in total on Oct 5, 2026. Shares held after the trade: 782,881 (-3.7%).

Value
$831K
Shares
30,000
Price
$27.70
Role
Director
Holding change
-3.7%
Trade date
Oct 5, 2026
4:00 PM ET Form 4
Insider Selling Alignment Healthcare, Inc. ALHC

Alignment Healthcare CMO Hyong Kim Sells $270K of Stock

Hyong Kim, CMO, sold 32,479 shares of Alignment Healthcare, Inc. at $8.30 a share, worth $270K in total on Oct 6, 2026. Shares held after the trade: 299,271 (-9.8%).

Value
$270K
Shares
32,479
Price
$8.30
Role
CMO
Holding change
-9.8%
Trade date
Oct 6, 2026
3:45 PM ET Form 4
Insider Selling Emergent BioSolutions Inc. EBS

Emergent BioSolutions Insider Donald W. DeGolyer Sells $126K of Stock

Donald W. DeGolyer sold 17,800 shares of Emergent BioSolutions Inc. at $7.09 a share, worth $126K in total on Oct 7, 2026. Shares held after the trade: 111,921 (-13.7%).

Value
$126K
Shares
17,800
Price
$7.09
Holding change
-13.7%
Trade date
Oct 7, 2026
3:31 PM ET 8-K
Loan & Debt Fatpipe Inc FATN

Fatpipe $6M Debt Financing with KeyBank National Association

FatPipe, Inc. entered into a $4.5 million secured term loan and a $1.5 million secured revolving line of credit with KeyBank. The proceeds from the term loan were used to refinance an existing SBA loan with Fortis Bank, resulting in an expected 110 basis point reduction in the company's annual borrowing rate.

Value
$6M
Counterparty
KeyBank National Association
Term
3 years
3:15 PM ET 8-K
Dividend Copper Property CTL Pass Through Trust CPPTL

Copper Property CTL Pass Through Trust Dividend

Copper Property CTL Pass Through Trust announced a monthly cash distribution of $0.076725 per trust certificate. The distribution is payable on October 13, 2026, to certificateholders of record as of October 12, 2026. The filing also includes the Trust's monthly reporting package for the period ending September 30, 2026.

3:10 PM ET 8-K
Capital Raise Ares Core Infrastructure Fund

Ares Core Infrastructure Fund Capital Raise of $768M

Ares Core Infrastructure Fund agreed to sell multiple classes of common shares for an aggregate purchase price of $767.8 million in its October 2026 monthly closing. The shares were sold in an unregistered private placement exempt from registration requirements, with the price per share tied to the fund's net asset value as of September 30, 2026.

Value
$768M
3:03 PM ET Form 4
Insider Buying Origin Real Estate Credit Fund

Origin Real Estate Credit Fund Insider Lawrence B. Stoller Buys $10K of Stock

Lawrence B. Stoller bought 1,019 shares of Origin Real Estate Credit Fund at $9.81 a share, worth $10K in total on Oct 5, 2026. Shares held after the trade: 3,522 (+40.7%).

Value
$10K
Shares
1,019
Price
$9.81
Holding change
+40.7%
Trade date
Oct 5, 2026
2:59 PM ET 8-K
Executive Compensation Tessera Defense & Homeland Security Inc. HLSQ

Tessera Defense & Homeland Security Executive Compensation

Tessera Defense and Homeland Security entered into a formal employment agreement with CEO Michael Oster, who has served without pay since March 2026. The agreement includes a monthly salary of approximately $18,000, a 50% cash bonus target, and a significant equity package consisting of 1 million RSUs, 1 million stock options, and performance-based shares tied to EBITDA-per-share targets for 2027 and 2028.

2:54 PM ET 8-K
Executive Compensation T3 Defense Inc. DFNS

T3 Defense Executive Compensation

T3 Defense Inc. appointed Shlomo Zakai as Chief Financial Officer, effective October 5, 2026. Under a consulting agreement, Mr. Zakai will receive a monthly fee of $13,000 plus VAT for his services. He previously served as CFO of Duke Robotics Corp. and Water IO Ltd.

Counterparty
Shlomo Zakai
Term
Indefinite

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.